Clinical Trial Update: Efficacy of Intravenous Infusions of Stem Cells in the Treatment of COVID-19 Patients [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial reports on the efficacy of intravenous stem cell infusions in patients with Coronavirus Infection (COVID-19).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronavirus Infection

Drugs mentioned

• Stem cell infusions

Snippet

Sponsor: Jinnah Hospital | Conditions: Corona Virus Infection | Phase 2 | Status: COMPLETED